MCMi (Medical Countermeasures Initiative) Program Update: FY 2019

Source: U.S. Food and Drug Administration (FDA). Published: 3/2020. This 53-page annual report details the Food and Drug Administration (FDA)'s medical countermeasures (MCM) activities in fiscal year (FY) 2019 (October 1, 2018 – September 30, 2019). FDA’s overarching objective with respect to MCMs is to facilitate the timely development of and access to safe and effective MCMs to counter chemical, biological, radiological, and nuclear (CBRN) and emerging infectious disease threats for civilian populations, as well as MCMs to support American military personnel. (PDF)
Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - Category: International Medicine & Public Health Source Type: news